Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravenous Aminophylline for Acute Severe Asthma in Children Over Two Years Receiving Inhaled Bronchodilators." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439576/0/repview. Accessed 21 May 2024.
Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439576/0/repview. Accessed May 21, 2024.
Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439576/0/repview
Intravenous Aminophylline for Acute Severe Asthma in Children Over Two Years Receiving Inhaled Bronchodilators [Internet]. In: Cochrane Abstracts. [cited 2024 May 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439576/0/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators
ID - 439576
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439576/0/repview
DB - Evidence Central
DP - Unbound Medicine
ER -